- $2.27bn
- $2.48bn
- $1.99bn
- 78
- 48
- 79
- 77
Annual income statement for AAR, fiscal year end - May 31st, USD millions except per share, conversion factor applied.
2019 May 31st | 2020 May 31st | 2021 May 31st | 2022 May 31st | 2023 May 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 2,052 | 2,072 | 1,652 | 1,820 | 1,991 |
| Cost of Revenue | |||||
| Gross Profit | 330 | 269 | 276 | 313 | 370 |
| Selling / General / Administrative Expenses | |||||
| Unusual Expense / Income | |||||
| Other Operating Expenses | |||||
| Total Operating Expenses | 1,954 | 2,031 | 1,587 | 1,715 | 1,857 |
| Operating Profit | 98.3 | 41.3 | 65 | 105 | 133 |
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | 89 | 30.4 | 64.5 | 105 | 121 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | 79 | 24.8 | 46.3 | 78.5 | 89.8 |
| Net Income Before Extraordinary Items | |||||
| Extraordinary Items | |||||
| Net Income | 7.5 | 4.4 | 35.8 | 78.7 | 90.2 |
| Adjustments to Net Income | |||||
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | 7.1 | 4.3 | 35.4 | 78.1 | 89.1 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | 2.25 | 1.97 | 1.02 | 2.25 | 2.54 |
| Dividends per Share |